Dose-escalation Study of a Contrast Agent for Delineation of Urological Anatomy in Minimally Invasive Surgery

Completed · Phase 1/Phase 2

Conditions studied: Intraoperative Ureter Injury

In brief

The purpose of this clinical trial is to study the safety and efficacy of an investigational imaging agent for delineation/visualization of urologic anatomy in the setting of minimally invasive surgery.

Key facts

Study ID
NCT03106038
Run by
Li-Cor, Inc.
People needed
41
Starts
2017-04-26
Expected to finish
2018-11-19
Last updated by the study team
2019-11-26

Who can join

Age: 19 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.